-
Je něco špatně v tomto záznamu ?
Short-interval intravenous indocyanine green administration in pediatric laparoscopic cholecystectomy: a prospective evaluation of visualization and safety
V. Dotlacil, E. Pajerova, D. Sovadinova, B. Kucerova, M. Vyhnanek, M. Rygl
Jazyk angličtina Země Německo
Typ dokumentu časopisecké články, pozorovací studie
- MeSH
- barvicí látky aplikace a dávkování škodlivé účinky MeSH
- časové faktory MeSH
- chirurgie s pomocí počítače * metody MeSH
- cholecystektomie laparoskopická * škodlivé účinky metody MeSH
- délka operace MeSH
- délka pobytu MeSH
- dítě MeSH
- indokyanová zeleň * aplikace a dávkování škodlivé účinky MeSH
- injekce intravenózní MeSH
- lidé MeSH
- mladiství MeSH
- optické zobrazování * škodlivé účinky metody MeSH
- pooperační komplikace epidemiologie MeSH
- předoperační péče škodlivé účinky metody MeSH
- prospektivní studie MeSH
- studie proveditelnosti MeSH
- žlučové ústrojí diagnostické zobrazování MeSH
- Check Tag
- dítě MeSH
- lidé MeSH
- mladiství MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- pozorovací studie MeSH
PURPOSE: Indocyanine green (ICG) fluorescence imaging enhances biliary visualization during pediatric laparoscopic cholecystectomy (LC), helping to identify anatomical variants and prevent bile duct injury. Standard pediatric recommendations suggest ICG administration 16-24 h preoperatively; however, this may be impractical. This study aims to evaluate the safety and effectiveness of short-interval ICG administration. METHODS: A prospective single-center study (October 2024-June 2025) included pediatric LC patients receiving intravenous Verdye® preoperatively. Visualization of extrahepatic biliary anatomy was assessed intraoperatively using a 5-point Likert scale, HELPFUL (usefulness), and DISTURBED (liver background interference) scores. Data included indication, ICG timing, operative time, and complications according to the Clavien-Dindo classification (C-D). RESULTS: Eleven patients (64% female), median age 14 years (IQR 12,7-15,7) and median weight 65,5 kg (IQR 46,5-80), were included. Five had BMI > 25 kg/m2; five (46%) underwent preoperative ERCP. ICG (median dose 0.34 mg/kg) was administered a median of 225 min before surgery. Median operative time was 65 min (IQR 58-68). Median Likert score was 5; HELPFUL 3; DISTURBED 1. No ICG-related or C-D complications occurred. CONCLUSION: Short-interval ICG administration was safe, feasible, and effective in enhancing biliary visualization during pediatric LC. This approach was well-tolerated and provided high-quality imaging without complications.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25021940
- 003
- CZ-PrNML
- 005
- 20251023075952.0
- 007
- ta
- 008
- 251014s2025 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00383-025-06172-x $2 doi
- 035 __
- $a (PubMed)40859062
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Dotlacil, Vojtech $u Department of Paediatric Surgery, Second Faculty of Medicine, Charles University and Motol University Hospital, Charles University, V Uvalu 84, Praha 5, 150 06, Prague, Czech Republic. vojtech.dotlacil@fnmotol.cz
- 245 10
- $a Short-interval intravenous indocyanine green administration in pediatric laparoscopic cholecystectomy: a prospective evaluation of visualization and safety / $c V. Dotlacil, E. Pajerova, D. Sovadinova, B. Kucerova, M. Vyhnanek, M. Rygl
- 520 9_
- $a PURPOSE: Indocyanine green (ICG) fluorescence imaging enhances biliary visualization during pediatric laparoscopic cholecystectomy (LC), helping to identify anatomical variants and prevent bile duct injury. Standard pediatric recommendations suggest ICG administration 16-24 h preoperatively; however, this may be impractical. This study aims to evaluate the safety and effectiveness of short-interval ICG administration. METHODS: A prospective single-center study (October 2024-June 2025) included pediatric LC patients receiving intravenous Verdye® preoperatively. Visualization of extrahepatic biliary anatomy was assessed intraoperatively using a 5-point Likert scale, HELPFUL (usefulness), and DISTURBED (liver background interference) scores. Data included indication, ICG timing, operative time, and complications according to the Clavien-Dindo classification (C-D). RESULTS: Eleven patients (64% female), median age 14 years (IQR 12,7-15,7) and median weight 65,5 kg (IQR 46,5-80), were included. Five had BMI > 25 kg/m2; five (46%) underwent preoperative ERCP. ICG (median dose 0.34 mg/kg) was administered a median of 225 min before surgery. Median operative time was 65 min (IQR 58-68). Median Likert score was 5; HELPFUL 3; DISTURBED 1. No ICG-related or C-D complications occurred. CONCLUSION: Short-interval ICG administration was safe, feasible, and effective in enhancing biliary visualization during pediatric LC. This approach was well-tolerated and provided high-quality imaging without complications.
- 650 _2
- $a prospektivní studie $7 D011446
- 650 12
- $a indokyanová zeleň $x aplikace a dávkování $x škodlivé účinky $7 D007208
- 650 12
- $a optické zobrazování $x škodlivé účinky $x metody $7 D061848
- 650 _2
- $a žlučové ústrojí $x diagnostické zobrazování $7 D001659
- 650 12
- $a chirurgie s pomocí počítače $x metody $7 D025321
- 650 _2
- $a barvicí látky $x aplikace a dávkování $x škodlivé účinky $7 D004396
- 650 12
- $a cholecystektomie laparoskopická $x škodlivé účinky $x metody $7 D017081
- 650 _2
- $a injekce intravenózní $7 D007275
- 650 _2
- $a časové faktory $7 D013997
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a dítě $7 D002648
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a studie proveditelnosti $7 D005240
- 650 _2
- $a předoperační péče $x škodlivé účinky $x metody $7 D011300
- 650 _2
- $a délka operace $7 D061646
- 650 _2
- $a pooperační komplikace $x epidemiologie $7 D011183
- 650 _2
- $a délka pobytu $7 D007902
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a pozorovací studie $7 D064888
- 700 1_
- $a Pajerova, Eliska $u Department of Paediatric Surgery, Second Faculty of Medicine, Charles University and Motol University Hospital, Charles University, V Uvalu 84, Praha 5, 150 06, Prague, Czech Republic
- 700 1_
- $a Sovadinova, Dagmar $u Department of Paediatric Surgery, Second Faculty of Medicine, Charles University and Motol University Hospital, Charles University, V Uvalu 84, Praha 5, 150 06, Prague, Czech Republic
- 700 1_
- $a Kucerova, Barbora $u Department of Paediatric Surgery, Second Faculty of Medicine, Charles University and Motol University Hospital, Charles University, V Uvalu 84, Praha 5, 150 06, Prague, Czech Republic
- 700 1_
- $a Vyhnanek, Martin $u Department of Paediatric Surgery, Second Faculty of Medicine, Charles University and Motol University Hospital, Charles University, V Uvalu 84, Praha 5, 150 06, Prague, Czech Republic
- 700 1_
- $a Rygl, Michal $u Department of Paediatric Surgery, Second Faculty of Medicine, Charles University and Motol University Hospital, Charles University, V Uvalu 84, Praha 5, 150 06, Prague, Czech Republic
- 773 0_
- $w MED00003742 $t Pediatric surgery international $x 1437-9813 $g Roč. 41, č. 1 (2025), s. 269
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40859062 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20251014 $b ABA008
- 991 __
- $a 20251023075957 $b ABA008
- 999 __
- $a ok $b bmc $g 2417020 $s 1260103
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 41 $c 1 $d 269 $e 20250826 $i 1437-9813 $m Pediatric surgery international $n Pediatr Surg Int $x MED00003742
- LZP __
- $a Pubmed-20251014